Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis.
PaperCitations, authors & open-access status
Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 75 citations, 2021 year and green oa status.
75
Citations
2021
Year
green
OA Status